Citigroup
IQMDU

Citigroup’s Intelligent Medicine Acquisition Corp. Unit IQMDU Stock Holding History

Citigroup’s Portfolio IQMDU Stock Details IQMDU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-50,000
Closed -$510K – 6759
2021
Q4 		$510K Buy
+50,000
New +$507K ﹤0.01% 3777

Other funds holding IQMDU

Calamos Advisors
Calamos Advisors Naperville, Illinois $30.1B AUM 30.03% 1-Year Est. Return
HIM
HGC Investment Management Toronto, Ontario, Canada $507M AUM 6.15% 1-Year Est. Return
CCA
Castle Creek Arbitrage Avon, Colorado $425M AUM 7.4% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $26.8B AUM 68.38% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $11B AUM 3.37% 1-Year Est. Return
MP
Mangrove Partners Greenwich, Connecticut $1.52B AUM 36.54% 1-Year Est. Return
WC
Wealthspring Capital West Harrison, New York $448M AUM 8.38% 1-Year Est. Return
SFM
Spartan Fund Management Toronto, Ontario, Canada $30M AUM 11.98% 1-Year Est. Return
DCM
Difesa Capital Management New York $38.1M AUM 39.86% 1-Year Est. Return

Citigroup's IQMDU Position: Q1 2022 in Review

Citigroup sold out of Intelligent Medicine Acquisition Corp. Unit (IQMDU) in Q1 2022, closing a stake of 50,000 shares — an estimated $510K sold.

Citigroup first reported a position in IQMDU in Q4 2021 and held it in 1 quarter. The position peaked at $510K in Q4 2021. 26 funds tracked by Wall St. Rank hold IQMDU as of Q1 2022.

  • Citigroup reported no remaining Intelligent Medicine Acquisition Corp. Unit position as of Q1 2022 after selling out during the quarter.
  • Citigroup sold 50,000 Intelligent Medicine Acquisition Corp. Unit shares in Q1 2022, an estimated $510K.
  • Citigroup first reported a position in Intelligent Medicine Acquisition Corp. Unit in Q4 2021 and held it in 1 quarter.
  • Citigroup's Intelligent Medicine Acquisition Corp. Unit position peaked at $510K in Q4 2021.
  • 26 funds tracked by Wall St. Rank held Intelligent Medicine Acquisition Corp. Unit as of Q1 2022.

Based on Citigroup's 13F filing for Q1 2022, filed 12 May 2022.